Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias

Muscle and Nerve

Volumn 52, Issue 6, 2015, Pages 927-932

  Wakerley, Benjamin R ^a,b   Yuki, Nobuhiro ^c  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bell palsy; Bifacial weakness; Facial diplegia; Guillain Barr syndrome; Miller Fisher syndrome; Paraesthesia

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

BIFACIAL WEAKNESS; CLINICAL FEATURE; DEMYELINATING DISEASE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; FACIAL NERVE PARALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; MUSCLE WEAKNESS; PARESTHESIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; CLASSIFICATION; COMPLICATION;

FACIAL PARALYSIS; GUILLAIN-BARRE SYNDROME; HUMANS; MUSCLE WEAKNESS; PARESTHESIA;

EID: 84955211220     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24887     Document Type: Review

References (54)

1. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012;366:2294-2304.
2. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
3. Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, Hirata K, et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 2008;255:674-682.
4. Wakerley BR, Yuki N. Pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2014;85:339-344.
5. Wakerley BR, Yuki N. Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome. J Neurol 2015 Feb 26. [Epub ahead of print].
6. Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculo-névrite avec hyperalbuminose du liquide cephalorachidien sans reaction cellulaire. Bull Soc Med Hôp Paris 1916;40:1462-1470.
7. Guillain G. Les polyradiculonévrites avec dissociation albumino cytologique et à évolution favorable (syndrome de Guillain et Barré). J Belge Neurol Psychiatry 1938;38:323-329.
8. Charous DI, Saxe BI. The Landry-Guillain-Barré syndrome: report of an unusual case, with a comment on Bell's palsy. N Engl J Med 1962;267:1334-1338.
9. Ropper AH. Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol 1994;51:671-675.
10. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: F.A. Davis; 1991.
11. Susuki K, Koga M, Hirata K, Isogai E, Yuki N. A Guillain-Barré syndrome variant with prominent facial diplegia. J Neurol 2009;256:1899-1905.
12. Susuki K, Atsumi M, Koga M, Hirata K, Yuki N. Acute facial diplegia and hyperreflexia: a Guillain-Barré syndrome variant. Neurology 2004;62:825-827.
13. Umapathi T, Tan EY, Kokubun N, Verma K, Yuki N. Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders. J Neurol Neurosurg Psychiatry 2012;83:941-948.
14. Arai M, Susuki K, Koga M. Axonal pharyngeal-cervical-brachial variant of Guillain-Barré syndrome without Anti-GT1a IgG antibody. Muscle Nerve 2003;28:246-250.
15. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;3:677-679.
16. Nagashima T, Koga M, Odaka M, Hirata K, Yuki N. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Arch Neurol 2007;64:1519-1523.
17. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104-1106.
18. Wakerley BR, Yuki N. Infectious and noninfectious triggers in Guillain-Barré syndrome. Expert Rev Clin Immunol 2013;9:627-639.
19. Orlikowski D, Porcher R, Sivadon-Tardy V, Quincampoix JC, Raphaël JC, Durand MC, et al. Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis 2011;52:837-644.
20. Tan EK, Lim SH, Wong MC, Chan LL. Facial diplegia: cranial variant of Guillain-Barré syndrome? J R Soc Med 1999;92:26-27.
21. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-S24.
22. Tatsumoto M, Misawa S, Kokubun N, Sekiguchi Y, Hirata K, Kuwabara S, et al. Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes. Muscle Nerve 2015;51:811-814.
23. Teng HW, Sung JY. Ptosis as the initial presentation of Guillain-Barré syndrome. J Emerg Med 2012;43:e283-285.
24. Wakerley BR, Uncini A, Yuki N, GBS Classification Group. Guillain-Barré and Miller Fisher syndromes: new diagnostic classification. Nat Rev Neurol 2014;10:537-544.
25. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 2014;137:33-43.
26. Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barré syndrome: a critical revision and the need for an update. Clin Neurophysiol 2012;123:1487-1495.
27. Carswell C, Northey LC, Davies L, Yuki N, Kiernan MC. Progressive bilateral facial weakness. Pract Neurol 2015;15:76-79.
28. Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 1994;44:1198-1202.
29. Clark JR, Carlson RD, Sasaki CT, Pachner AR, Steere AC. Facial paralysis in Lyme disease. Laryngoscope 1985;95:1341-1345.
30. Terada K, Niizuma T, Kosaka Y, Inoue M, Ogita S, Kataoka N. Bilateral facial nerve palsy associated with Epstein-Barr virus infection with a review of the literature. Scand J Infect Dis 2004;36:75-77.
31. Balatsouras DG, Kaberos A, Korres S, Leontiadis A, Kandiloros D. Infectious causes of bilateral facial nerve palsy. J Otolaryngol 2007;36:E42-44.
32. Hamano T, Takano A, Miyao S, Teramoto J, Wanibe S. Bilateral facial palsy following trigeminal zoster with zoster oticus. Intern Med 2000;39:80-81.
33. James DG, Sharma OP. Neurological complications of sarcoidosis. J R Soc Med 1967;62:1169-1170.
34. Stern BJ, Krumholz A, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985;42:909-917.
35. Glocker FX, Seifert C, Lücking CH. Facial palsy in Heerfordt's syndrome: electrophysiological localization of the lesion. Muscle Nerve 1999;22:1279-1282.
36. Uchihara T, Yoshida S, Tsukagoshi H. Bilateral facial paresis with Sjögren's syndrome. J Neurol 1989;236:186.
37. Adour KK, Byl FM, Hilsinger RL, Kahn ZM, Sheldon MI. The true nature of Bell's palsy: analysis of 1, 000 consecutive patients. Laryngoscope 1978;88:787-801.
38. Hauser WA, Karnes WE, Annis J, Kurland LT. Incidence and prognosis of Bell's palsy in the population of Rochester, Minnesota. Mayo Clin Proc 1971;46:258-264.
39. Gilden DH. Bell's palsy. N Engl J Med 2004;351:1323-1331.
40. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996;124:27-30.
41. Furuta Y, Takasu T, Sato KC, Fukuda S, Inuyama Y, Nagashima K. Latent herpes simplex virus type 1 in human geniculate ganglia. Acta Neuropathol 1992;84:39-44.
42. Sartoretti-Schefer S, Wichmann W, Valavanis A. Idiopathic, herpetic, and HIV-associated facial nerve palsies: abnormal MR enhancement patterns. AJNR Am J Neuroradiol 1994;15:479-485.
43. Kohler A, Chofflon M, Sztajzel R, Magistris MR. Cerebrospinal fluid in acute peripheral facial palsy. J Neurol 1999;246:165-169.
44. Serrano P, Hernández N, Arroyo JA, de Llobet JM, Domingo P. Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis 2007;44:e57-61.
45. Bélec L, Gherardi R, Georges AJ, Schüller E, Vuillecard E, Di Costanzo B, et al. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J Neurol 1989;236:411-414.
46. Chia LG. Facial weakness without ocular weakness in myasthenia gravis. Muscle Nerve 1988;11:185-186.
47. Bogousslavsky J, Perentes E, Regli F, Deruaz JP. Polymyositis with severe facial involvement. J Neurol 1982;228:277-281.
48. Kiwak KJ, Levine SE. Benign intracranial hypertension and facial diplegia. Arch Neurol 1984;41:787-788.
49. Al-Noury K, Lotfy A. Normal and pathological findings for the facial nerve on magnetic resonance imaging. Clin Radiol 2011;66:701-707.
50. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. Q J Med 2009;102:449-460.
51. Hughes RAC, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev 2012;CD001446.
52. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 2014;10:469-482.
53. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-230.
54. Teixeira LJ, Valbuza JS, Prado GF. Physical therapy for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2011:CD006283.